Contribution of No‐reflow phenomenon to hepatic injury after ischemia‐reperfusion: Evidence for a role for superoxide anion

Anthony Koo, Hirokazu Komatsu, Gongming Tao, Masayashu Inoue, Paul H. Guth, Neil Kaplowitz – 1 March 1992 – Controversy exists as to the role of oxygen‐derived free radicals in tissue injury and the no‐reflow phenomenon in reperfusion injury after ischemia. In this study using an experimental rat model, left hepatic lobar ischemia followed by reperfusion resulted in an increase of serum glutamic pyruvic transaminase at 30 min with concomitant histological evidence of hepatocellular necrosis at 24 hr.

Mitogenic effects of hepatic stimulator substance on cultured nonparenchymal liver epithelial cells

Sanjeev Gupta, Douglas R. LaBrecque, David A. Shafritz – 1 March 1992 – We determined whether hepatic stimulator substance shares its mitogenic specificity for hepatocytes with nonparenchymal epithelial cells in the hepatocyte lineage. Cell lines designated HTC (derived from a rat hepatoma known to respond to hepatic stimulator substance) and FNRL, K‐16 and K‐22 (derived from rat liver nonparenchymal epithelial cells) were used.

Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats

Margaret Swain, Roger F. Butterworth, Andres T. Blei – 1 March 1992 – The pathogenesis of brain edema in acute liver failure is poorly understood. We have previously shown that rats with ischemic acute liver failure (portacaval anastomosis followed by hepatic artery ligation) exhibit brain edema and intracranial hypertension, with swelling of cortical astrocytes as the most prominent neuropathological abnormality.

Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: Implications for hepatitis C virus replication in infected tissue

Tetsuo Takehara, Norio Hayashi, Eiji Mita, Hideki Hagiwara, Keiji Ueda, Kazuhiro Katayama, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada – 1 March 1992 – The combination of reverse transcription and polymerase chain reaction is a very powerful tool for the detection of hepatitis C virus RNA in sera of patients with hepatitis C virus infection. However, when studying the presence of this virus in tissue using polymerase chain reaction, it may be difficult to distinguish between blood viral particles adhering to the tissue and viral RNA contained within the tissue.

Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis

Patrick S. C. Leung, Takashi Iwayama, Thomas Prindiville, David T. Chuang, Aftab A. Ansari, R. Max Wynn, Rollie Dickson, Ross Coppel, M. Eric Gershwin – 1 March 1992 – The appearance of autoantibodies against mitochondria in patients with primary biliary cirrhosis has been known for more than 25 yr. In the past, based on the biochemical complexity of the mitochondrion and the use of crude extracts for immunodiagnosis, a degree of nonspecificity in assaying for antibodies to mitochondria has been present.

Presence of functionally active cytochrome P‐450IIE1 in the plasma membrane of rat hepatocytes

Defeng Wu, Arthur I. Cederbaum – 1 March 1992 – Recent experiments have described the presence of cytochrome P‐450 and certain P‐450 isozymes in the plasma membrane of rat liver. Experiments were carried out to evaluate whether cytochrome P‐450IIE1 was present in the plasma membrane fraction of livers from control rats and rats treated with 4‐methylpyrazole, which induces this isozyme.

Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2‐hydroxy‐1‐naphthylaldehyde using the hepatocyte in culture

Erica Baker, Des Richardson, Sharon Gross, Prem Ponka – 1 March 1992 – A range of new analogues of the promising iron chelator pyridoxal isonicotinoyl hydrazone was prepared and assessed for activity in reducing hepatocyte iron, mechanism of action and potential in iron‐chelation therapy.

Enhancement in antioxidant‐based hepatoprotective activity of trolox by its conjugation to lactosylphenylpyranoside

Tai‐Wing Wu, Zdenek B. Pristupa, Ling‐Hua Zeng, Jian‐Xun Au, Jun Wu, Hiroshi Sugiyama, Doug Carey – 1 March 1992 – When Trolox (a polar analog of vitamin E) is conjugated to p‐aminophenyl‐β‐D‐lactopyranoside, the resulting lactosylphenyl Trolox becomes a markedly more stable and effective hepatoprotector than Trolox. In primary rat hepatocytes exposed to xanthine oxidase–hypoxanthine, lactosylphenyl Trolox prolonged cell survival better than did Trolox, mannitol or ascorbate.

Subscribe to